Amalgamated Bank Purchases 5,095 Shares of Teleflex Incorporated (NYSE:TFX)

Amalgamated Bank grew its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 56.9% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 14,046 shares of the medical technology company's stock after buying an additional 5,095 shares during the period. Amalgamated Bank's holdings in Teleflex were worth $1,941,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 100 shares during the period. Headlands Technologies LLC acquired a new position in shares of Teleflex during the 4th quarter worth approximately $29,000. Whipplewood Advisors LLC grew its position in shares of Teleflex by 7,700.0% during the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after purchasing an additional 231 shares in the last quarter. True Wealth Design LLC lifted its holdings in shares of Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock worth $48,000 after acquiring an additional 104 shares during the period. Finally, UMB Bank n.a. boosted its position in Teleflex by 3,763.6% in the first quarter. UMB Bank n.a. now owns 425 shares of the medical technology company's stock valued at $59,000 after buying an additional 414 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Analysts Set New Price Targets

TFX has been the subject of a number of analyst reports. Truist Financial lowered their target price on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Morgan Stanley lowered their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. Wells Fargo & Company decreased their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, May 2nd. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Finally, Wall Street Zen lowered shares of Teleflex from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $164.63.

Teleflex Trading Up 0.9%

Shares of TFX traded up $1.10 during trading hours on Thursday, reaching $120.03. 444,206 shares of the company traded hands, compared to its average volume of 632,319. Teleflex Incorporated has a 12-month low of $115.94 and a 12-month high of $249.91. The stock's fifty day moving average price is $122.04 and its 200 day moving average price is $144.57. The firm has a market cap of $5.30 billion, a price-to-earnings ratio of 37.86, a PEG ratio of 1.87 and a beta of 1.08. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The company had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. During the same period in the prior year, the firm earned $3.21 earnings per share. The firm's revenue for the quarter was down 5.0% compared to the same quarter last year. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were issued a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a yield of 1.13%. Teleflex's dividend payout ratio is presently 42.90%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.